Literature DB >> 29697866

Etiologies and predictors of 30-day readmissions in patients undergoing percutaneous mechanical circulatory support-assisted percutaneous coronary intervention in the United States: Insights from the Nationwide Readmissions Database.

Chirag Bavishi1, Alejandro Lemor1, Vrinda Trivedi2, Saurav Chatterjee3, Pedro Moreno1, John Lasala4, Herbert D Aronow5, J Dawn Abbott5.   

Abstract

BACKGROUND: Patients undergoing percutaneous mechanical circulatory support (pMCS)-assisted percutaneous coronary intervention (PCI) represent a high-risk group vulnerable to complications and readmissions. HYPOTHESIS: Thirty-day readmissions after pMCS-assisted PCI are common among patients with comorbidities and account for a significant amount of healthcare spending.
METHODS: Patients undergoing PCI and pMCS (Impella, TandemHeart, or intra-aortic balloon pump) for any indication between January 1, 2012, and November 30, 2014, were selected from the Nationwide Readmissions Database. Patients were identified using appropriate ICD-9-CM codes. Clinical risk factors and complications were analyzed for association with 30-day readmission.
RESULTS: Our analysis included 29 247 patients, of which 4535 (15.5%) were readmitted within 30 days. On multivariate analysis, age ≥ 65 years, female sex, hypertension, diabetes, chronic lung disease, heart failure, prior implantable cardioverter-defibrillator, liver disease, end-stage renal disease, and length of stay ≥5 days during index hospitalization were independent predictors of 30-day readmission. Cardiac etiologies accounted for ~60% of readmissions, of which systolic or diastolic heart failure (22%), stable coronary artery disease (11.1%), acute coronary syndromes (8.9%), and nonspecific chest pain (4.0%) were the most common causes. In noncardiac causes, sepsis/septic shock (4.6%), hypotension/syncope (3.2%), gastrointestinal bleed (3.1%), and acute kidney injury (2.6%) were among the most common causes of 30-day readmissions. Mean length of stay and cost of readmissions was 4 days and $16 191, respectively.
CONCLUSIONS: Thirty-day readmissions after pMCS-assisted PCI are common and are predominantly associated with increased burden of comorbidities. Reducing readmissions for common cardiac etiologies could save substantial healthcare costs.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Cost; Etiology; Mechanical Circulatory Support; Percutaneous Coronary Intervention; Readmission

Mesh:

Year:  2018        PMID: 29697866      PMCID: PMC6489704          DOI: 10.1002/clc.22893

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  21 in total

1.  Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention: insights from the National Cardiovascular Data Registry.

Authors:  Amneet Sandhu; Lisa A McCoy; Smita I Negi; Irfan Hameed; Prashant Atri; Subhi J Al'Aref; Jeptha Curtis; Ed McNulty; H Vernon Anderson; Adhir Shroff; Mark Menegus; Rajesh V Swaminathan; Hitinder Gurm; John Messenger; Tracy Wang; Steven M Bradley
Journal:  Circulation       Date:  2015-08-18       Impact factor: 29.690

2.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

3.  2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiología Intervencionista; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention.

Authors:  Charanjit S Rihal; Srihari S Naidu; Michael M Givertz; Wilson Y Szeto; James A Burke; Navin K Kapur; Morton Kern; Kirk N Garratt; James A Goldstein; Vivian Dimas; Thomas Tu
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

4.  Factors associated with 30-day readmission rates after percutaneous coronary intervention.

Authors:  Farhan J Khawaja; Nilay D Shah; Ryan J Lennon; Joshua P Slusser; Aziz A Alkatib; Charanjit S Rihal; Bernard J Gersh; Victor M Montori; David R Holmes; Malcolm R Bell; Jeptha P Curtis; Harlan M Krumholz; Henry H Ting
Journal:  Arch Intern Med       Date:  2011-11-28

5.  Readmission after inpatient percutaneous coronary intervention in the Medicare population from 2000 to 2012.

Authors:  Christian McNeely; Stephen Markwell; Christina M Vassileva
Journal:  Am Heart J       Date:  2016-07-14       Impact factor: 4.749

6.  Thirty-Day Readmissions After Transcatheter Aortic Valve Replacement in the United States: Insights From the Nationwide Readmissions Database.

Authors:  Dhaval Kolte; Sahil Khera; M Rizwan Sardar; Neil Gheewala; Tanush Gupta; Saurav Chatterjee; Andrew Goldsweig; Wilbert S Aronow; Gregg C Fonarow; Deepak L Bhatt; Adam B Greenbaum; Paul C Gordon; Barry Sharaf; J Dawn Abbott
Journal:  Circ Cardiovasc Interv       Date:  2017-01       Impact factor: 6.546

7.  Hospital strategies associated with 30-day readmission rates for patients with heart failure.

Authors:  Elizabeth H Bradley; Leslie Curry; Leora I Horwitz; Heather Sipsma; Yongfei Wang; Mary Norine Walsh; Don Goldmann; Neal White; Ileana L Piña; Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-07

Review 8.  Reducing hospital readmission rates: current strategies and future directions.

Authors:  Sunil Kripalani; Cecelia N Theobald; Beth Anctil; Eduard E Vasilevskis
Journal:  Annu Rev Med       Date:  2013-10-21       Impact factor: 13.739

9.  Use of Mechanical Circulatory Support in Percutaneous Coronary Intervention in the United States.

Authors:  Rohan Khera; Peter Cram; Mary Vaughan-Sarrazin; Phillip A Horwitz; Saket Girotra
Journal:  Am J Cardiol       Date:  2015-10-23       Impact factor: 2.778

10.  Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.

Authors:  Ajay J Kirtane; Darshan Doshi; Martin B Leon; John M Lasala; E Magnus Ohman; William W O'Neill; Adhir Shroff; Mauricio G Cohen; Igor F Palacios; Nirat Beohar; Nir Uriel; Navin K Kapur; Dimitri Karmpaliotis; William Lombardi; George D Dangas; Manish A Parikh; Gregg W Stone; Jeffrey W Moses
Journal:  Circulation       Date:  2016-08-02       Impact factor: 39.918

View more
  4 in total

Review 1.  Outcomes With Left Ventricular Assist Device in End-Stage Renal Disease: A Systematic Review.

Authors:  Sofia Lakhdar; Mahmoud Nassar; Chandan Buttar; Laura M Guzman Perez; Shahzad Akbar; Anoosh Zafar; Most Munira
Journal:  Cureus       Date:  2022-04-18

2.  Etiologies and predictors of 30-day readmissions in patients undergoing percutaneous mechanical circulatory support-assisted percutaneous coronary intervention in the United States: Insights from the Nationwide Readmissions Database.

Authors:  Chirag Bavishi; Alejandro Lemor; Vrinda Trivedi; Saurav Chatterjee; Pedro Moreno; John Lasala; Herbert D Aronow; J Dawn Abbott
Journal:  Clin Cardiol       Date:  2018-04-26       Impact factor: 2.882

3.  Relationship between dynamic changes of peri-procedure anxiety and short-term prognosis in patients undergoing elective percutaneous coronary intervention for coronary heart disease: A single-center, prospective study.

Authors:  Yao-Yao Hu; Ya-Jing Cai; Xin Jiang; Fang-Ying Mao; Jing Zhang; Lin Liu; Qing Wu; Xiao-Hua Wang
Journal:  PLoS One       Date:  2022-04-01       Impact factor: 3.240

4.  Predicting the Risk of Unplanned Readmission at 30 Days After PCI: Development and Validation of a New Predictive Nomogram.

Authors:  Wenjun Xu; Hui Tu; Xiaoyun Xiong; Ying Peng; Ting Cheng
Journal:  Clin Interv Aging       Date:  2022-07-05       Impact factor: 3.829

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.